Previous studies have demonstrated that continuous infusion of apelin-overexpressing WJ-MSCs can elevate insulin and C-peptide levels in the plasma of T2DM rats, indicating a potential therapeutic effect on the metabolic dysfunction characterizing this condition [12]. The gene discussed is APLN; the disease is type 2 diabetes mellitus.